tecovirimat will raise the stage or outcome of diazepam by impacting hepatic enzyme CYP2C19 metabolism. Use Caution/Keep track of. Tecovirimat is often a weak inhibitor of CYP2C8 and CYP2C19. Observe for adverse results if coadministered with sensitive substrates of these enzymes.Reserve concomitant prescribing of those medicine in people for whom